DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Schneeweiss A, Ettl J, Lüftner D. et al.
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer – Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany.

Breast 2020;
54: 88-95

Download Bibliographical Data

Access:
Access: